|
CAMK2G expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64099955846098E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10580000103988E-08 |
| Normal-vs-Stage2 |
2.437700E-04 |
| Normal-vs-Stage3 |
7.52089945876833E-10 |
| Normal-vs-Stage4 |
2.22889995349362E-09 |
| Stage1-vs-Stage2 |
6.084000E-01 |
| Stage1-vs-Stage3 |
5.708300E-02 |
| Stage1-vs-Stage4 |
4.234400E-02 |
| Stage2-vs-Stage3 |
8.637500E-02 |
| Stage2-vs-Stage4 |
4.431500E-02 |
| Stage3-vs-Stage4 |
6.010400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12539993885252E-11 |
| Normal-vs-AfricanAmerican |
1.739410E-03 |
| Normal-vs-Asian |
5.67219999999535E-05 |
| Caucasian-vs-AfricanAmerican |
2.542200E-01 |
| Caucasian-vs-Asian |
3.987000E-01 |
| AfricanAmerican-vs-Asian |
6.755000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5367000005817E-08 |
| Normal-vs-Female |
5.64649993428645E-10 |
| Male-vs-Female |
9.720000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.03130000095319E-08 |
| Normal-vs-Age(41-60Yrs) |
4.53339998873759E-09 |
| Normal-vs-Age(61-80Yrs) |
2.69509999983875E-07 |
| Normal-vs-Age(81-100Yrs) |
6.218000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.584800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.365400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.671800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.524400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.847600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.476400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.427200E-04 |
| Classical-VS-Follicular |
3.066000E-02 |
| Classical-VS-Other |
3.972200E-01 |
| Classical-VS-Normal |
6.00170024789293E-10 |
| Tall-VS-Follicular |
2.3579999999912E-05 |
| Tall-VS-Other |
4.880600E-01 |
| Tall-VS-Normal |
2.51719756150237E-11 |
| Follicular-VS-Other |
1.749180E-01 |
| Follicular-VS-Normal |
7.560400E-04 |
| Other-VS-Normal |
2.180600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08340000004592E-06 |
| Normal-vs-N1 |
1.26669996713957E-09 |
| N0-vs-N1 |
3.775900E-03 |
|
|
